Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@kevin__mak

Kevin Mak on X

$QURE A bunch has been written about today's AMT130 news by people far more scientifically credible than me, so I'll just summarize to say my opinion is that the data was directionally bearish but only mildly. I think the reaction to the news was overblown. If you gave me the press release and conference call ahead of time and asked me to guess "what does the price trade to", I'd say around $32. Lots of people have complained about the type and quality of disclosure and messaging from the company but I want to highlight something I noticed that I think has been missed. My experience this morning was that the actual press release process was entirely mishandled. Here's what I think happened: 7:05AM ET is the "typical release time" for QURE. So naturally when they setup an interview with Stat News and Bloomberg the night before, they likely communicated this "embargo time". So at 7:05AM, the pre-written articles from Stat and Bloomberg hit the newswires. Bloomberg's article was particularly poorly done, with exceptionally little detail beyond the "-44% not stat sig" datapoint. (They later "updated" their news article to be more robust). But this awful article was essentially first to hit the headlines, and obviously thousands of bots and machines are scraping Bloomberg, and trading off it. Naturally one would want to "check for more data beyond two articles", but for some reason, at 7:05AM, there was no Press Release from QURE. This was likely a mistake (either by QURE or by the wire company). In the screenshot (and link) below, you'll see the timestamp of the official wire including ALL of the data. So investors were "left in the dark" for a full 7 minutes. https://t.co/zp4lmZqFfe Does 7 minutes really matter? To a long term investor, certainly not. But it matters to algo traders, who leave footprints of price action, which affect sentiment, so it does matter. Also, it leaves me unsettled that they're possibly getting some of the most basic things wrong. I get their jobs are stressful and there's a lot on the line here, that's why you have to dot your i's, cross your t's, because everything matters. To be clear, I don't know for a fact who's error this was, but I'd speculate it was the company. (Here's a normal press release from the company timestamped at 7:05AM ET. There are many other examples on the site that corroborate the 7:05 ET pattern) https://t.co/miNzObOZP7 Disclosure: Creek Drive and its affiliated funds hold a long position in QURE. Views expressed are current opinions for information only, subject to change and are not investment advice or a recommendation to buy or sell any security. Investing involves the risk of loss and past performance is not indicative of future performance. See the disclosures link in my bio for more important information.

Investor Letters

All letters

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 6 clicks

eToro: Expanding Beyond Crypto

EToro trades at 2.89x EV/FCF with $304 million in trailing free cash flow, expanding from crypto into equities, commodities, currencies and…

ETOR $1.9B
Max Arnoldi 5 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 5 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

AA $10BNKE $60B
Aurelion Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 5 clicks

Coupang: 3Q26 Business Recap

Coupang’s product-commerce growth rose 9% as data-leak effects fade, while management expects margins to return to pre-incident levels by…

CPNG $27B
Speedwell Memos 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 279

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.